Chemoinformaics analysis of TRANS-TRANS-FARNESOL
| Molecular Weight | 294.555 | nRot | 9 |
| Heavy Atom Molecular Weight | 260.283 | nRig | 3 |
| Exact Molecular Weight | 294.238 | nRing | 0 |
| Solubility: LogS | -6.754 | nHRing | 0 |
| Solubility: LogP | 7.614 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 59.063 |
| nHD | 0 | BPOL | 51.285 |
| QED | 0.36 |
| Synth | 3.029 |
| Natural Product Likeliness | 1.411 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.942 |
| Pgp-sub | 0.004 |
| HIA | 0.003 |
| CACO-2 | -4.601 |
| MDCK | 0.000011 |
| BBB | 0.008 |
| PPB | 1.0056 |
| VDSS | 7.695 |
| FU | 0.00822396 |
| CYP1A2-inh | 0.935 |
| CYP1A2-sub | 0.391 |
| CYP2c19-inh | 0.33 |
| CYP2c19-sub | 0.838 |
| CYP2c9-inh | 0.747 |
| CYP2c9-sub | 0.806 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.177 |
| CYP3a4-inh | 0.209 |
| CYP3a4-sub | 0.158 |
| CL | 5.03 |
| T12 | 0.096 |
| hERG | 0.02 |
| Ames | 0.003 |
| ROA | 0.001 |
| SkinSen | 0.954 |
| Carcinogencity | 0.287 |
| EI | 0.967 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.652365 |